Most recent update: Tuesday, October 17, 2017 - 13:13

Bariatric News - Cookies & privacy policy

You are here

Long-term RYGB outcomes

Ten year outcomes shows durability of RYGB

Study shows long-term reduction in comorbidities

Roux-en-y gastric bypass is a durable operation for long-term weight loss and treatment of obesity-related comorbid disease, according to researchers from the University of Virginia, Charlottesville, VA. The study, which included 1,087 patients who underwent RYGB procedures over a 20-year study period (1985–2004), reported that excess body mass index significantly improved over time and a significant decrease in obesity-related comorbid disease persisted at ten years of follow-up after RYGB.

The study, ‘10-year Outcomes After Roux-en-Y Gastric Bypass’, published in the Annals of Surgery, by researchers from the University of Virginia, Charlottesville, VA, was designed to evaluate the clinical effectiveness and long-term durability of RYGB, and is believed to be the largest American series with a ten-year follow-up after RYGB. The researchers examined differences in pre-operative comorbidities, operative characteristics (laparoscopic vs. open), post-operative complications, annual weight loss, and current comorbidities ten years after surgery.

Outcomes

After ten years, the researchers had complete data on 60% of patients (n=651 from 1,087 patients). They report that 335 patients (51.5%) underwent open RYGB and 316 (48.5%) had laparoscopic RYGB, with 34 patients (10.8% of the laparoscopic patients) requiring conversion to open.

The researchers report that laparoscopic patients were more likely to be white (p=0.001) and older (p=0.004), with a lower incidence of psychiatric (p=0.002) comorbidities and gallstones (p=0.001). They also found that laparoscopic patients were more likely to have had a previous cholecystectomy (p=0.021). The mean preoperative BMI was lower in the laparoscopic (51.4) versus the open (54.1) group (p=0.001).

In comparison, the open group was found to have a longer operative time (p=0.017) with higher rates of incisional hernia (p=0.025) and lower incidence of dumping syndrome (p=0.015).

However, no differences were found in comorbidity resolution, % total body weight loss and % excess BMI loss between the groups. Percentage excess BMI loss peaked at 74% by 24 months, with 52% at ten years (both p<0.001).

“Our data confirm the long-term durability of RYGB for patients with morbid obesity. Given the current culture of value-driven health care, with an eye on quality and cost, it is more important than ever to provide the most efficient and effective treatment for the growing obesity epidemic...Roux-en-Y Gastric Bypass remains an excellent and durable operation for long-term weight loss and treatment of obesity-related comorbid disease,” the authors conclude. “Laparoscopic RYGB results in highly favourable outcomes with reduced incisional hernia rates. These ten-year data help to more clearly define long-term outcomes and demonstrate outstanding reduction in comorbid disease after RYGB.”

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox.